返回
BioInvent International AB（BOVNF）價格
BOVNF 股價走勢圖
BOVNF 股票價格預測
BioInvent International AB
$0
0%
$0
收盤價：Feb 13, 16:00:00 GMT-5
$0
0%
$0
盤後：Feb 13, 20:00:00 GMT-5
關鍵數據
前收市價
--
開盤價
--
當日範圍
-
52週區間
-
交易量
--
平均成交量
--
每股盈餘 (TTM)
--
股息收益率
--
市值
--
什麼是 BIOINVENT INTERNATIONAL AB？
BioInvent International AB is a clinical-stage biotech company that discovers and develops novel and immuno-modulatory antibodies for cancer therapy. The company is headquartered in Lund, Skane and currently employs 124 full-time employees. The company went IPO on 2001-06-12. The Company’s operational activities are focused on expanding the clinical development of human antibodies, such as BI-1206, BI-1808, BI-1607 and BT-001. The firm has one wholly-owned subsidiary BioInvent Finans AB, which engaged in the administration of warrants issued by the Company.